IL34 and lung carcinoma: Chemoresistant lung cancer cells secrete IL‐34, which is associated with immune suppression by inducing the M2‐like phenotype of TAMs,37 and co‐expression of IL‐34 and CSF‐1 in cancer cells is correlated with a worse clinical course in patients with lung cancer.38